Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Recent studies have indicated a higher prevalence of primary aldosteronism (PA) than
reported historically. Aldosterone excess induces sodium and fluid retention with …

Great strides have been made in our understanding of the pathophysiology of primary
aldosteronism syndrome since Conn's description of the clinical presentation of a patient …

Objective: To develop clinical practice guidelines for the management of patients with
primary aldosteronism. Participants: The Task Force included a chair, selected by the …

Objective: Our objective was to develop clinical practice guidelines for the diagnosis and
treatment of patients with primary aldosteronism. Participants: The Task Force comprised a …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, with improved screening methodologies, it appears that primary …

Primary aldosteronism (PA) may account for as many as 10%–14% of hypertension cases.
The plasma aldosterone concentration/plasma renin activity ratio is a simple screening test …

Since its initial description in 1955, primary aldosteronism was thought to be a rare cause of
hypertension. However, improved screening methods show that primary aldosteronism is a …

Primary aldosteronism (PA) is an important and commonly unrecognized cause of
secondary hypertension. Idiopathic hyperaldosteronism and aldosterone-producing …

Primary aldosteronism (PA) comprises two main subtypes: unilateral aldosteronism, mainly
caused by aldosterone-producing adenoma; and bilateral adrenal hyperplasia. Establishing …